Funding for this research was provided by:
Received: 8 December 2021
Accepted: 4 February 2022
First Online: 14 February 2022
: This study received an approval from Integreview/Advarra Institutional Review Board (IRB) and all study participants were consented.
: All authors provide consent for publication of this manuscript.
: All authors listed are employees of ObvioHealth. The first author is a principal investigator of this observational study who is responsible for the ObvioHealth study site.